ArticleBMC cardiovascular disorders2021

Intermittent concurrent use of clopidogrel and proton pump inhibitors did not increase risk of adverse clinical outcomes in Chinese patients with coronary artery disease.

Wanbing He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.